SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 416.41 |
| Enterprise Value ($M) | 561.49 |
| Book Value ($M) | -33.97 |
| Book Value / Share | -0.23 |
| Price / Book | -12.26 |
| NCAV ($M) | -67.70 |
| NCAV / Share | -0.45 |
| Price / NCAV | -6.15 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.76 |
| Return on Assets (ROA) | -0.50 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.84 |
| Current Ratio | 2.37 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 188.77 |
| Assets | 222.51 |
| Liabilities | 256.48 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 127.04 |
| Operating Income | -93.02 |
| Net Income | -110.56 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -58.79 |
| Cash from Investing | 18.00 |
| Cash from Financing | 54.11 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Deep Track Capital, LP | 0.00 | -100.00 | |
| 13G/A | Baker Bros. Advisors Lp | 4.99 | -3.07 | |
| 13G/A | Great Point Partners Llc | 0.00 | -100.00 | |
| 13G/A | Vanguard Group Inc | 5.56 | 6.82 | |
| 13G/A | Franklin Resources Inc | 4.30 | -46.03 | |
| 13G/A | Jpmorgan Chase & Co | 0.00 | -98.75 | |
| 13G/A | BlackRock Inc. | 4.70 | -27.08 | |
| 13D/A | Rubric Capital Management LP | 19.00 | 127.35 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 300,346 | 1,690,642 | 17.77 | |
| 312,299 | 1,488,901 | 20.98 | |
| 137,330 | 1,583,951 | 8.67 | |
| 271,529 | 613,536 | 44.26 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| HEPA – Hepion Pharmaceuticals, Inc. | HOOK – HOOKIPA Pharma Inc. |
| HOTH – Hoth Therapeutics, Inc. | ICCC – ImmuCell Corporation |
| IKT – Inhibikase Therapeutics, Inc. |